Visgeneer Inc. (TPEX:4197)

Market Cap	272.23M -16.5%
Revenue (ttm)	159.76M +33.9%
Net Income	-1.21M
EPS	-0.04
Shares Out	30.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,123
Average Volume	13,639
Open	9.10
Previous Close	9.42
Day's Range	9.02 - 9.10
52-Week Range	8.65 - 11.80
Beta	-0.11
RSI	27.26
Earnings Date	Apr 21, 2026

About Visgeneer

Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 98
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4197

Financial Performance

In 2024, Visgeneer's revenue was 115.76 million, a decrease of -21.78% compared to the previous year's 147.99 million. Losses were -17.73 million, -9.50% less than in 2023.